Literature DB >> 19327914

Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.

Ik Jae Lee1, Woong Sub Koom, Chang Geol Lee, Yong Bae Kim, Sei Whan Yoo, Ki Chang Keum, Gwi Eon Kim, Eun Chang Choi, In Ho Cha.   

Abstract

PURPOSE: To analyze risk factors and the dose-effect relationship for osteoradionecrosis (ORN) of the mandible after radiotherapy of oral and oropharyngeal cancers.
MATERIALS AND METHODS: One-hundred ninety-eight patients with oral (45%) and oropharyngeal cancer (55%) who had received external radiotherapy between 1990 and 2000 were retrospectively reviewed. All patients had a dental evaluation before radiotherapy. The median radiation dose was 60 Gy (range, 16-75 Gy), and the median biologically effective dose for late effects (BED(late)) in bone was 114 Gy(2) (range, 30-167 Gy(2)).
RESULTS: The frequency of ORN was 13 patients (6.6%). Among patients with mandibular surgery, eight had ORN at the surgical site. Among patients without mandibular surgery, five patients had ORN on the molar area of the mandible. The median time to ORN was 22 months (range, 1-69 months). Univariate analysis revealed that mandibular surgery and Co-60 were significant risk factors for ORN (p = 0.01 and 0.04, respectively). In multivariate analysis, mandibular surgery was the most important factor (p = 0.001). High radiation doses over BED 102.6 Gy(2) (conventional dose of 54 Gy at 1.8 Gy/fraction) were also a significant factor for ORN (p = 0.008) and showed a positive dose-effect relationship in logistic regression (p = 0.04) for patients who had undergone mandibular surgery.
CONCLUSIONS: Mandibular surgery was the most significant risk factor for ORN of mandible in oral and oropharyngeal cancers patients. A BED of 102.6 Gy(2) or higher to the mandible also significantly increases the risk of ORN.

Entities:  

Mesh:

Year:  2009        PMID: 19327914     DOI: 10.1016/j.ijrobp.2008.12.052

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  36 in total

1.  Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.

Authors: 
Journal:  Radiother Oncol       Date:  2017-07-18       Impact factor: 6.280

2.  Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study.

Authors:  Pei-Hsun Liao; Chi-Hsiang Chu; Yao-Min Hung; Pei-Ling Tang; Tsu-Jen Kuo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

3.  Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.

Authors:  Angela T T Wong; Stephen Y Lai; G Brandon Gunn; Beth M Beadle; Clifton D Fuller; Martha P Barrow; Theresa M Hofstede; Mark S Chambers; Erich M Sturgis; Abdallah Sherif Radwan Mohamed; Jan S Lewin; Katherine A Hutcheson
Journal:  Oral Oncol       Date:  2017-01-21       Impact factor: 5.337

4.  Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.

Authors:  Manupol Tangthongkum; Virat Kirtsreesakul; Pasawat Supanimitjaroenporn; Peesit Leelasawatsuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-20       Impact factor: 2.503

5.  The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.

Authors:  Adepitan A Owosho; C Jillian Tsai; Ryan S Lee; Haley Freymiller; Arvin Kadempour; Spyridon Varthis; Adi Z Sax; Evan B Rosen; SaeHee K Yom; Joseph Randazzo; Esther Drill; Elyn Riedel; Snehal Patel; Nancy Y Lee; Joseph M Huryn; Cherry L Estilo
Journal:  Oral Oncol       Date:  2016-12-03       Impact factor: 5.337

Review 6.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.

Authors:  Matthew J Krasin; Louis S Constine; Debra L Friedman; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

7.  Osteoradionecrosis in patients with salivary gland malignancies.

Authors:  J Rhet Tucker; Li Xu; Erich M Sturgis; Abdallah S R Mohamed; Theresa M Hofstede; Mark S Chambers; Stephen Y Lai; Clifton David Fuller; Beth Beadle; G Brandon Gunn; Katherine A Hutcheson
Journal:  Oral Oncol       Date:  2016-03-31       Impact factor: 5.337

8.  Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck : First clinical experience with vismodegib for locally advanced disease.

Authors:  Björn Schulze; Markus Meissner; Shahram Ghanaati; Iris Burck; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2015-10-08       Impact factor: 3.621

9.  A Histomorphometric Analysis of Radiation Damage in an Isogenic Murine Model of Distraction Osteogenesis.

Authors:  Alexander R Zheutlin; Sagar S Deshpande; Noah S Nelson; Yekaterina Polyatskaya; Jose J Rodriguez; Alexis Donneys; Steven R Buchman
Journal:  J Oral Maxillofac Surg       Date:  2015-08-07       Impact factor: 1.895

10.  Periodontal Treatment in Cancer Patients: An Interdisciplinary Approach.

Authors:  A M Decker; L S Taichman; N J D'Silva; R S Taichman
Journal:  Curr Oral Health Rep       Date:  2018-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.